LBL-043, a novel LILRB4xCD3 T cell engager, for the treatment of LILRB4 positive leukemia

被引:0
|
作者
Dang, Yujia
Huang, Xiao
Qin, Yurong
Liu, Xiaoya
Chen, Min
Jiang, Duqing
Wu, Guojin
Ye, Mi
Sun, Jianming
Wang, Baohui
Guan, Jing
Li, Tingting
Zhu, Jordan
Lai, Shoupeng
Kang, Xiaoqiang
Ling, Hong
机构
关键词
D O I
10.1158/1538-7445.AM2024-6712
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
6712
引用
收藏
页数:3
相关论文
共 34 条
  • [1] Lbl-043, a Novel LILRB4xCD3 T Cell Engager, for the Treatment of Relapsed/Refractory Multiple Myeloma
    Dang, Yujia
    Huang, Xiao
    Qin, Yurong
    Liu, Xiaoya
    Chen, Min
    Jiang, Duqing
    Ye, Mi
    Wu, Guojin
    Sun, Jianming
    Guan, Jing
    Zhu, Jordan
    Cai, Shengli
    Lai, Shoupeng
    Kang, Xiaogiang
    Ling, Hong
    BLOOD, 2024, 144 : 5827 - 5827
  • [2] ATG-102, a novel LILRB4 x CD3 T cell engager, targeting two nonoverlapping epitopes of LILRB4, for the treatment of monocytic AML
    Sun, Ao
    Gao, Mengshi
    Guo, Rong
    Liu, Huiling
    Hu, Zaoshun
    Zheng, Enlin
    Hui Yuwen
    Chen, Peng
    Mei, Jay
    Shan, Bo
    Hou, Bing
    CANCER RESEARCH, 2024, 84 (06)
  • [3] LILRB4 Signaling in Leukemia Cells Mediates T Cell Suppression and Tumor Infiltration
    Deng, Mi
    Gui, Xun
    Kim, Jaehyup
    Zheng, Junke
    Zhang, Ningyan
    An, Zhiqiang
    Zhang, Chengcheng
    BLOOD, 2018, 132
  • [4] LILRB4 Is a Novel Target for KMT2A Rearranged Acute Leukemia
    Smith, Caroline
    Huang, Ryan
    Xie, Jingjing
    Liu, Xiaoye
    He, Yubo
    Ludwig, Kathleen
    Klesse, Laura
    Zhang, Chengcheng
    John, Samuel
    BLOOD, 2022, 140 : 7423 - 7424
  • [5] Correction to: LILRB4 ITIMs mediate the T cell suppression and infiltration of acute myeloid leukemia cells
    Zunling Li
    Mi Deng
    Fangfang Huang
    Changzhu Jin
    Shuang Sun
    Heyu Chen
    Xiaoye Liu
    Licai He
    Ali H. Sadek
    Cheng Cheng Zhang
    Cellular & Molecular Immunology, 2020, 17 : 302 - 304
  • [6] The intracellular domain of LILRB4 mediates T cell suppression and infiltration of acute myeloid leukemia cells
    Li, Z.
    Deng, M.
    Huang, F.
    Shuang, S.
    Jin, C.
    Chen, H.
    He, L.
    Zhang, C.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 96 - 96
  • [7] LILRB4 signalling in leukaemia cells mediates T cell suppression and tumour infiltration
    Deng, Mi
    Gui, Xun
    Kim, Jaehyup
    Xie, Li
    Chen, Weina
    Li, Zunling
    He, Licai
    Chen, Yuanzhi
    Chen, Heyu
    Luo, Weiguang
    Lu, Zhigang
    Xie, Jingjing
    Churchill, Hywyn
    Xu, Yixiang
    Zhou, Zhan
    Wu, Guojin
    Yu, Chenyi
    John, Samuel
    Hirayasu, Kouyuki
    Nam Nguyen
    Liu, Xiaoye
    Huang, Fangfang
    Li, Leike
    Deng, Hui
    Tang, Haidong
    Sadek, Ali H.
    Zhang, Lingbo
    Huang, Tao
    Zou, Yizhou
    Chen, Benjamin
    Zhu, Hong
    Arase, Hisashi
    Xia, Ningshao
    Jiang, Youxing
    Collins, Robert
    You, M. James
    Homsi, Jade
    Unni, Nisha
    Lewis, Cheryl
    Chen, Guo-Qiang
    Fu, Yang-Xin
    Liao, X. Charlene
    An, Zhiqiang
    Zheng, Junke
    Zhang, Ningyan
    Zhang, Cheng Cheng
    NATURE, 2018, 562 (7728) : 605 - +
  • [8] LILRB4 signalling in leukaemia cells mediates T cell suppression and tumour infiltration
    Mi Deng
    Xun Gui
    Jaehyup Kim
    Li Xie
    Weina Chen
    Zunling Li
    Licai He
    Yuanzhi Chen
    Heyu Chen
    Weiguang Luo
    Zhigang Lu
    Jingjing Xie
    Hywyn Churchill
    Yixiang Xu
    Zhan Zhou
    Guojin Wu
    Chenyi Yu
    Samuel John
    Kouyuki Hirayasu
    Nam Nguyen
    Xiaoye Liu
    Fangfang Huang
    Leike Li
    Hui Deng
    Haidong Tang
    Ali H. Sadek
    Lingbo Zhang
    Tao Huang
    Yizhou Zou
    Benjamin Chen
    Hong Zhu
    Hisashi Arase
    Ningshao Xia
    Youxing Jiang
    Robert Collins
    M. James You
    Jade Homsi
    Nisha Unni
    Cheryl Lewis
    Guo-Qiang Chen
    Yang-Xin Fu
    X. Charlene Liao
    Zhiqiang An
    Junke Zheng
    Ningyan Zhang
    Cheng Cheng Zhang
    Nature, 2018, 562 : 605 - 609
  • [9] A novel bispecific LILRB4/CD3 antibody with potent killing of monocytic acute myeloid leukemia cells
    Huang, Tao
    Hong, Kyu
    McCutcheon, Krista
    Ma, Jing-Tyan
    Zhu, Ying
    Deng, Mi
    Zhang, Cheng Cheng
    Woodard, Paul
    Xiang, Hong
    Schebye, Xiao Min
    Liao, X. Charlene
    CANCER RESEARCH, 2023, 83 (08)
  • [10] Development of LILRB4 biparatopic synthetic T-cell receptor and antigen receptor (STAR)-T cells for the treatment of acute myeloid leukemia (AML)
    Rui, Wei
    Lei, Lei
    Zhang, Zezhong
    Wu, Chunyan
    Xia, Yu
    Liu, Yingying
    Pang, Xiaojing
    Du, Ruifang
    Wang, Lan
    Sheng, Dengyue
    Guo, Jing
    Zhang, Yanyan
    Zhao, Xueqiang
    Pan, James
    CANCER RESEARCH, 2023, 83 (07)